Aurobindo Pharma gets USFDA gesture for Flucytosine Capsules Kumar Jeetendra | May 4, 2020 Aurobindo Pharma Limited has gotten last endorsement from the US Food and Drug Administration (USFDA) to make and market Flucytosine Capsules, 250 mg and 500 mg. Flucytosine Capsules are conventional adaptation of Bausch Health’s Ancobon® Capsules. The item will be propelled in June 2020. The endorsed item has an expected market size of US$ 43 …
